|
1
|
A Case of Perimenopausal Endometrial Cancer in a Woman with MSH2 Germline Mutation.
|
J Menopausal Med
|
2013
|
1.06
|
|
2
|
Hereditary risk evaluation for borderline ovarian tumors based on immunohistochemistry.
|
J Menopausal Med
|
2014
|
0.99
|
|
3
|
Endometrial cancer occurence five years after breast cancer in BRCA2 mutation patient.
|
Obstet Gynecol Sci
|
2015
|
0.95
|
|
4
|
Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma.
|
Oncotarget
|
2015
|
0.77
|
|
5
|
Clinical significance of mismatch repair genes immunohistochemical expression of complex endometrial hyperplasia.
|
Obstet Gynecol Sci
|
2015
|
0.75
|